Gene
Therapy
involves insertion of genetic material into cells of the patients to
provide them a new function or to restore the missing or
inappropriate functioning of the cells due to cancer or gene
mutations. Scientists have created personalized medicines that are
used to learn about a person’s genetic makeup and untangle the
biologic nature of the patient’s cancerous cells for carrying out
such therapies.
Depending on the type of therapy, personalized gene therapy
treatments for cancer market is differentiated into two segments
which are as follows:
• Targeted treatments
• Pharmacogenomics
Download
PDF Brochure of Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/60
On the basis of application, the personalized gene therapy
treatments for cancer market is analyzed into:
• Breast Cancer
• Leukemia
• Head & Neck Cancer
• Prostate Cancer
• Pancreatic Cancer
• Leukemia Cancer
• Melanoma
• Ovarian Cancer
• Brain Cancer
• Colorectal Cancer
• Lung Cancer
• Liver Cancer
• Bladder Cancer
• Lymphoma
Geographically, the personalized gene therapy treatments for cancer
market has been analyzed into North America, Europe, Asia Pacific,
Latin America, Middle East, and Africa.
Competitive Landscape:
The major players in the customized gene therapy treatments for
cancer market include Amgen, Inc., SynerGene Therapeutics, Inc.,
Chengdu Shi Endor Biological Engineering Technology Co., Ltd., Cold
Genesys, Inc., Takara Bio, Inc., Bellicum Pharmaceuticals, Inc.,
Ziopharm Oncology, Inc., OncoSec Medical, Inc., Sevion Therapeutics,
Inc., and Burzynski Clinic.
Personalized Gene Therapy Treatments for Cancer Market Potential
Applications:
Targeted treatments are focused on cancer specific genes, tissues or
the protein environment that contribute towards the cancer survival
and growth. Researchers identify new targeted cells and develop and
test new drugs and medications for such targets as per patient needs.
In targeted treatments, the tumor cells themselves are targeted to
cure cancer. Breast cancer, gastrointestinal stromal tumor,
colorectal cancer, kidney cancer, melanoma, lung cancer, brain
cancer, multiple myeloma, certain childhood cancers and lymphoma, and
leukemia are the common types of cancers for which targeted
treatments are applied.
Pharmacogenomics, on the other hand, affect the processes occurring
in the body and drug responses. The difference in the processes
influences the safety and efficacy of a drug. The basic principle
behind the treatment is to activate the immune system cells that
could attack and destroy the cancerous cells. Moreover, in this case,
if the patients’ body does not respond to a medication, the drugs
stay in the blood stream for longer period of time and may cause
severe side effects. Therefore, this type of treatment carries a risk
of reaction of drug from person to person, providing targeted
treatment a preference over pharmacogenomics.
Personalized gene therapy treatments for cancer market involves
evaluation of the developed drugs through clinical trials. Government
support and funding and the advantages of personalized gene therapy
over other treatment options such as chemotherapy and surgery are the
major factors which are projected to drive growth of personalized
gene therapy treatments for cancer market. For instance, the U.S.
government has set up the MD Anderson Cancer Center Sheikh Khalifa
Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy in
Texas to support preclinical research and clinical trials for
targeted therapy for particular genes. Such government initiatives
are encouraging researchers to develop more effective personalized
gene therapy treatments for different types of cancer, thus boosting
growth of the cancer personalized gene therapy treatments market.
However, high costs associated with these treatments and the
unavailability of personalized gene therapy treatment for some types
of cancers is the major factor that is projected to restrain growth
of the personalized gene therapy treatments for cancer market.
Request
For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/60
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
No comments:
Post a Comment